Nucleotidase

18
Development of Potent & Selective Inhibitors of ecto -5ʹ -Nucleotidase Based on an Anthraquinone Scaffold KORA UPENDRA REDDY 2010H146037H 5 May 2011 1

Transcript of Nucleotidase

Page 1: Nucleotidase

Development of Potent & Selective Inhibitors

of ecto -5 -́Nucleotidase Based on an

Anthraquinone Scaffold

KORA UPENDRA REDDY

2010H146037H

5 May 2011 1

Page 2: Nucleotidase

Function of ecto Nucleotidases

Extracellular

Nucleotide Triphosphates

-Diphosphates

-Monophosphates

[ATP,AMP,UDP,UMP,GMP]

Nucleosides

Source of Extracellular

nucleotides

Nerve terminals

Hypoxic tissue

Salvage pathways

Cell membrane

transport

Damaged/dying cells

5 May 2011 2

Page 3: Nucleotidase

Families of ectonucleotidases

1) Ectonucleoside triphosphate diphosphohydrolases

(E-NTPDase).

2) Ectonucleotide pyrophosphate/phosphodiesterases

(E-NPPS).

3) Alkaline phosphatases.

4) Ecto-5ʹ -nucleotidase.

5 May 2011 3

Page 4: Nucleotidase

Receptors

• Extracellular nucleosides & nucleotides exert their action by

P1(adenosine receptor)

Subtypes

A1

A2a

A2b

A3

P2(Nucleotide receptor)

P2X[Ligand gated]

Short term processes

exocrine/endocrine

secretions

immune response

platelet aggregation

P2Y[G-protein coupled]

Long term processes

cell proliferation

differentiation

migration

5 May 2011 4

Page 5: Nucleotidase

5 May 2011 5

Page 6: Nucleotidase

NTPDase E-NPPS AP eN

Location Nervous tissue,

Golgi complex,

liver,

kidney

Expressed in

capillaries of

brain

Bone tissue All tissues

Mechani

sm

ATP,ADP to

AMP

ATP,ADP to

AMP

AMP to

Adenosine

AMP,

UMP,IMP

& GMP

to

Adenosine

Function Mediate the

termination of

ATP signaling in

the synaptic

cleft

Ectoenzymatic

catabolism of

extracellular

nucleotides

Development

&

mineralization

Of bones

Activates

the P1

receptors

by

producing

adenosine

5 May 2011 6

Page 7: Nucleotidase

5 May 2011 7

Page 8: Nucleotidase

Ectonucleotidase role in Tumor growth

5 May 2011 8

LPC=lyso phosphotidyl choline

LPA=lyso phosphotidic acid

Page 9: Nucleotidase

eN Inhibitors

5 May 2011 9

Page 10: Nucleotidase

Synthesis

Efficient microwave assisted Ullmann Reaction:

Reaction conditions:

pH=6-7

copper powder

microwave irradiation at 100-120 ͦ C

time =5 to 24 min

5 May 2011 10

Page 11: Nucleotidase

5 May 2011 11

Page 12: Nucleotidase

5 May 2011 12

SAR

Page 13: Nucleotidase

Lead moleculePosition Increased activity Decreased activity

C-2 -SO3H -CH3

C-4

Phenyl

ring

substituti

ons

Unsubstituted

phenyl amino ring

-OH at o-/p-

position of phenyl

Halogen at

p-position

Amino group at

p-position

Carboxylate at

o-position

Benzyl amino,

Phenethylamino

Replacement of

aromatic with

aliphatic residues

Methylated –OH.

Carboxylate at

m/p-position

5 May 2011 13

Page 14: Nucleotidase

Molecular modeling

5 May 2011 14

Page 15: Nucleotidase

Enzyme inhibition assays

Instrument : Capillary electrophoresis-UV method

High substrate concentrations were used because of low

sensitivity

Quantifying product: Adenosine

Ki values calculated by using IC-50 values

5 May 2011 15

Page 16: Nucleotidase

Selectivity

5 May 2011 16

Page 17: Nucleotidase

Toxicity

Hydroxyl substituted Anthraquinones bearing basic side chains

leads to carcinogenicity

Intercalate into DNA

Inhibit DNA topoisomerase II complex

Form reactive oxygen species

Lacking phenolic basic side chains found to be non toxic

5 May 2011 17

Page 18: Nucleotidase

Conclusion

During optimization five compounds [4,23,45,52,53]

showed more inhibitory effect with submicromolar

concentrations

Most potent compounds proved to be selective versus

other ecto nucleotidases & P2 receptors

Treatment for cancers

Anthraquinone scaffold appears to be privileged structure

of nucleotide binding protein targets

5 May 2011 18